moxifloxacin has been researched along with Thrombocytopenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acat, M; Benli, AR; Casim, H; Çetinkaya, E; Çörtük, M; Köroğlu, M; Yazıcı, O | 1 |
| Hartmann, B; Keller, F; Maus, S; Rothermund, L | 1 |
| Coker, TJ | 1 |
3 other study(ies) available for moxifloxacin and Thrombocytopenia
| Article | Year |
|---|---|
Moxifloxacin related thrombocytopeniae: A case report.
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines; Thrombocytopenia | 2016 |
Thrombocytopenia, INR prolongation and fall in fibrinogen under daptomycin.
Topics: Anti-Bacterial Agents; Aza Compounds; Daptomycin; Endocarditis, Bacterial; Fibrinogen; Fluoroquinolones; Humans; International Normalized Ratio; Male; Middle Aged; Moxifloxacin; Quinolines; Renal Dialysis; Staphylococcal Infections; Staphylococcus epidermidis; Thrombocytopenia; Vancomycin | 2011 |
Drug-induced immune thrombocytopenia due to moxifloxacin.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Diagnosis, Differential; Female; Fluoroquinolones; Humans; Immunity, Cellular; Moxifloxacin; Platelet Count; Quinolines; Respiratory Tract Infections; Thrombocytopenia | 2013 |